- Home
- ANIK vs SABA Comparison
ANIK vs SABA Comparison
Compare ANIK & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- SABA
- Stock Information
- Founded
- ANIK 1983
- SABA 1988
- Country
- ANIK United States
- SABA United States
- Employees
- ANIK N/A
- SABA N/A
- Industry
- ANIK Medical/Dental Instruments
- SABA
- Sector
- ANIK Health Care
- SABA
- Exchange
- ANIK Nasdaq
- SABA Nasdaq
- Market Cap
- ANIK 255.6M
- SABA 246.4M
- IPO Year
- ANIK 1993
- SABA N/A
- Fundamental
- Price
- ANIK $16.54
- SABA $8.87
- Analyst Decision
- ANIK Buy
- SABA
- Analyst Count
- ANIK 2
- SABA 0
- Target Price
- ANIK $24.50
- SABA N/A
- AVG Volume (30 Days)
- ANIK 95.2K
- SABA 290.0K
- Earning Date
- ANIK 10-31-2024
- SABA 01-01-0001
- Dividend Yield
- ANIK N/A
- SABA 12.91%
- EPS Growth
- ANIK N/A
- SABA N/A
- EPS
- ANIK N/A
- SABA N/A
- Revenue
- ANIK $164,168,000.00
- SABA N/A
- Revenue This Year
- ANIK N/A
- SABA N/A
- Revenue Next Year
- ANIK N/A
- SABA N/A
- P/E Ratio
- ANIK N/A
- SABA N/A
- Revenue Growth
- ANIK 0.52
- SABA N/A
- 52 Week Low
- ANIK $15.83
- SABA $3.64
- 52 Week High
- ANIK $29.12
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- ANIK 38.75
- SABA 49.76
- Support Level
- ANIK $15.83
- SABA $8.73
- Resistance Level
- ANIK $18.18
- SABA $9.14
- Average True Range (ATR)
- ANIK 0.62
- SABA 0.15
- MACD
- ANIK 0.05
- SABA -0.03
- Stochastic Oscillator
- ANIK 37.45
- SABA 32.27
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Templeton Global Income Fund is a closed-end fund. It seeks high current income, with a secondary goal of capital appreciation. Under normal market conditions. The Fund invests at least over 80% of its net assets in income-producing securities, including debt securities of the United States and foreign issuers, including emerging markets.